This site is intended for healthcare professionals
Drug information


Read time: 21 mins
Last updated: 06 May 2020
Published: 01 Apr 2021

4.1 Therapeutic indications

In adults, as an analgesic supplement for use before and during anaesthesia.

It is indicated for:

• Short procedures and outpatient surgery.

• Procedures of medium and long duration when given as a bolus followed by supplemental doses or by continuous infusion.

Alfentanil 500 micrograms/ml is indicated for use in neonates, infants, and children as:

• an opioid in association with a hypnotic to induce anaesthesia

• a narcotic analgesic in association with general anaesthesia and for both short and long surgical procedures

At very high doses, Alfentanil 500 micrograms/ml solution for injection may be used as an anaesthetic induction agent in ventilated patients.

Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.




The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC ( Medthority offers the whole library of SPC documents from eMC.

Medthority will not be held liable for explicit or implicit errors, or missing data.

Reporting of suspected adverse reactions 

Drug Licencing

Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).